Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Korea Investment Partners
AddedFeb 13, 2024
UpdatedJul 16, 2026
Korea Investment Partners

Korea Investment Partners

Operating

Korea Investment Partners: A venture capital firm specializing in equity investments across diverse sectors in South Korea.

Location
Seoul, Seoul, KR
Founded
1986
Firm
Compare
Portfolio
Employees
News

Investments

Twelve Labs
Twelve Labs
Series B

Total Raised

$127.1M

Rounds

5

Series B$100MJuly 2026
Seed$10MOctober 2023
Jenfi
Jenfi

Total Raised

$41.2M

Rounds

7

Series B$6.6MMay 2023
Series A$6.3MAugust 2021
Vedanta Biosciences
Vedanta Biosciences

Total Raised

$433.1M

Rounds

15

Series E$106.5MApril 2023
Timely Technology
Timely Technology

Total Raised

$100M

Rounds

1

Seed$100MFebruary 2023
Rgenta Therapeutics
Rgenta Therapeutics

Total Raised

$116.9M

Rounds

6

Series A$52MNovember 2022
Apposter
Apposter

Total Raised

$14B

Rounds

3

Series B$11BSeptember 2022
CashWalk
CashWalk

Total Raised

$30B

Rounds

1

Late Stage Private$30BApril 2022
Geneos Therapeutics
Geneos Therapeutics

Total Raised

$49.5M

Rounds

5

Series A$17MMarch 2022
Series A$12MMarch 2021
Adriel
Adriel

Total Raised

$19.5M

Rounds

4

Series B$13MMarch 2022
Rizzle
Rizzle

Total Raised

$37M

Rounds

5

Series B$10MMarch 2022
Pavilion Data Systems
Pavilion Data Systems
Series D

Total Raised

$103M

Rounds

9

Series D$45MJanuary 2022
Spatial
Spatial

Total Raised

$47.3M

Rounds

5

Series B$25MDecember 2021
OncoMyx Therapeutics
OncoMyx Therapeutics

Total Raised

$50M

Rounds

1

Series B$50MDecember 2021
Viron
Viron

Total Raised

$81M

Rounds

3

Series B$50MDecember 2021
GenEdit
GenEdit

Total Raised

$67.7M

Rounds

7

Series A$26MSeptember 2021
Tribe
Tribe

Rounds

2

Series UnknownApril 2021
Evos Esports
Evos Esports

Total Raised

$16.4M

Rounds

2

Series B$12MOctober 2020
Machbase
Machbase

Total Raised

$10B

Rounds

1

Series C$10BJuly 2020
QuotaBook
QuotaBook
Series A

Total Raised

$1B

Rounds

5

SeedJune 2020
Actym Therapeutics
Actym Therapeutics

Total Raised

$59.5M

Rounds

3

Series A$34MApril 2020
Ansun Biopharma
Ansun Biopharma
Public

Total Raised

$213.1M

Rounds

7

Series B$100MOctober 2019
Gushcloud
Gushcloud

Total Raised

$13M

Rounds

5

Series Unknown$11MSeptember 2019